Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1024

Mar 3, 2022

Progress, Potential, and Possibilities

Posted by in categories: biotech/medical, food, life extension, robotics/AI

https://www.youtube.com/c/ProgressPotentialandPossibilities/videos

Progress, Potential, And Possibilities has had another busy month! — Come subscribe & enjoy all of our fascinating guest who are creating a better tomorrow! #Health #Longevity #Biotech #Space #AI #Technology #Medicine #Entertainment #Energy #Regeneration #Environment #Sustainability #Food #Innovation #Future #Defense #STEM #Aging #IraPastor


Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us — Host — Ira S. Pastor.

Mar 2, 2022

Hypertonic saline solution with furosemide infusion may be beneficial in fluid overload in patients with reduced ejection fraction

Posted by in category: biotech/medical

Background: Diuretic-resistant fluid overload is a common problem encountered in hospitalized heart failure (HF) patients, with different interventions proposed to overcome it. Some studies have suggested that combining hypertonic saline with furosemide provided advantages over furosemide alone.

Study design: Systematic review and meta-analysis.

Setting: A comprehensive search of several databases from each database’s inception to March 17, 2020, and reference lists of retrieved articles and review articles in the field to identify additional publications.

Mar 2, 2022

Applications of the amniotic membrane in tissue engineering and regeneration: the hundred-year challenge

Posted by in categories: bioengineering, biotech/medical, life extension, nanotechnology

The amniotic membrane (Amnio-M) has various applications in regenerative medicine. It acts as a highly biocompatible natural scaffold and as a source of several types of stem cells and potent growth factors. It also serves as an effective nano-reservoir for drug delivery, thanks to its high entrapment properties. Over the past century, the use of the Amnio-M in the clinic has evolved from a simple sheet for topical applications for skin and corneal repair into more advanced forms, such as micronized dehydrated membrane, amniotic cytokine extract, and solubilized powder injections to regenerate muscles, cartilage, and tendons. This review highlights the development of the Amnio-M over the years and the implication of new and emerging nanotechnology to support expanding its use for tissue engineering and clinical applications. Graphical Abstract.

Mar 2, 2022

Disentangling Interactions Across Brain Areas

Posted by in categories: biotech/medical, neuroscience

Summary: Feedforward and feedback signaling involves different neural activity patterns. The findings shed new light on how the brain processes visual information.

Source: Carnegie Mellon University.

Exploring how brain areas communicate with each other is the focus of a long-standing research collaboration between Carnegie Mellon University, Albert Einstein College of Medicine, and Champalimaud Research.

Mar 2, 2022

Drawing up a ‘Google Earth’ of the human body

Posted by in category: biotech/medical

A new synchrotron-imaging technique is helping researchers shed a new light on human anatomy. Jon Cartwright zooms in.

Mar 2, 2022

The world’s first black-footed ferret clone could help its species avoid extinction

Posted by in categories: biotech/medical, existential risks

Mar 1, 2022

Inside Mark Zuckerberg’s plan to cure all diseases as he reveals views on death

Posted by in categories: biotech/medical, life extension

BILLIONAIRE Mark Zuckerberg has revealed his thoughts on life and death in a recent podcast.

The Facebook founder and Meta Platforms CEO has plans to cure all diseases this century but has no desire to live forever.

Continue reading “Inside Mark Zuckerberg’s plan to cure all diseases as he reveals views on death” »

Mar 1, 2022

Digital Twins: The Virtual Future Of Healthcare

Posted by in categories: biotech/medical, computing, neuroscience

While advancements in healthcare have come in leaps and bounds since the 20th century, there is perhaps none more exciting than what digital twin technology could offer. The healthcare industry has the potential to be revolutionized by this application of new advancements, which will ultimately lead to improved research capabilities and patient outcomes.

Defined as the virtual representation of a physical object or system across its life cycle, a digital twin is a computer program that uses real world data to create simulations that can predict the outcomes of a product or process. A concept initially utilized by NASA in the 1960s, this technology has grown exponentially in the last decade, now further expanding into the world of healthcare.

Beginning in 2014 with The Living Heart Project headed by Dassault Systémes, healthcare research with digital twins has broadened to include organs such as the brain and lungs, as well as projects for virtual parts of the body. With these models, doctors have the potential to discover undeveloped illnesses, experiment with treatments, and improve surgical outcomes. They allow clinicians to test multiple treatments across a vast range of therapies, equipment, and interventions by comparing possible outcomes without taking any risks in terms of patient safety. Ultimately, care can become more precise, targeted, and based on the most accurate data available when digital twins are utilized.

Mar 1, 2022

Dr. Adam Wolfberg, MD, MPH — Chief Medical Officer, Current Health — Quality Healthcare In The Home

Posted by in categories: biotech/medical, health, information science, wearables

Is the Chief Medical Officer at Current Health (https://currenthealth.com/), a Best Buy Health company (https://healthcare.bestbuy.com/) and part of the American multinational consumer electronics retailer.

Current Health is an organization that enables the delivery of healthcare services in the home to enable healthcare organizations to deliver high-quality, patient-centric care at a lower cost. The company integrates patient-reported data with data from biosensors – including their own continuous monitoring wearable devices – to provide healthcare organizations with actionable, real-time insights into the patient’s condition. Leveraging clinical algorithms that can be tailored to the individual patient, Current Health identifies when a patient needs clinical attention, allowing organizations to manage patient care remotely or coordinate in-home care via integrated service partners. The Current Health platform brings together tele-health capabilities, patient engagement tools, and in-home connectivity to provide a single solution to manage all care in the home. Dr. Wolfberg also leads implementation and account management at the organization.

Continue reading “Dr. Adam Wolfberg, MD, MPH — Chief Medical Officer, Current Health — Quality Healthcare In The Home” »

Mar 1, 2022

UC Berkeley loses CRISPR patent case, invalidating patent rights it granted gene-editing companies developing human therapies

Posted by in categories: biotech/medical, genetics, law

Ending the latest chapter in a years-long legal battle over who invented CRISPR, the U.S. Patent and Trademark Office ruled on Monday that the revolutionary genome editing technology belongs to the Broad Institute of Harvard and MIT.

The decision is a blow to the University of California and biotech companies that had licensed the technology from the university for use in developing treatments, including Intellia Therapeutics and CRISPR Therapeutics. They will now have to negotiate with the Broad Institute for the right to use CRISPR for human therapies.